共 408 条
[21]
Funovits J(2020)Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis Tohoku J Exp Med 86 753-1352
[22]
Felson DT(2019)Two-year abatacept retention rate in clinical practice in the French ACTION cohort Joint Bone Spine 170 132-3059
[23]
Bingham CO(2020)Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study Wien Med Wochenschr 5 3-undefined
[24]
Birnbaum NS(2021)Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study BMC Rheumatol 3 e000538-undefined
[25]
Burmester GR(2017)Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study RMD Open 34 489-undefined
[26]
Bykerk VP(2016)Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study Clin Exp Rheumatol 68 1346-undefined
[27]
Cohen MD(2016)Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the Pan-European registry analysis Arthritis Rheumatol 22 64-undefined
[28]
Combe B(2020)Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells Arthritis Res Ther 38 3049-undefined
[29]
Costenbader KH(2019)Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries Clin Rheumatol undefined undefined-undefined
[30]
Dougados M(undefined)undefined undefined undefined undefined-undefined